Kiromic BioPharma Inc. (KRBP)
OTC: KRBP
· Real-Time Price · USD
0.20
0.00 (0.05%)
At close: Mar 24, 2025, 3:59 PM
Kiromic BioPharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -6.49M | -7.35M | -6.91M | -6.15M | -4.69M | -4.19M | -6.76M | -5.3M | -7.07M | -11.86M | -8.44M | -7.37M | -10.64M | -6.12M | -4.97M | -3.85M |
Depreciation & Amortization | 568K | 552K | 557K | 557K | 555.6K | 560.1K | 549.6K | 556K | 554.9K | 536.6K | 399.1K | 182.8K | 136.4K | 131K | 106.8K | 95.6K |
Stock-Based Compensation | 192K | 319K | 29K | 57K | 58.8K | 26.4K | 35.4K | 21K | 609.6K | 363.2K | 184.2K | 80.1K | 443.8K | 1.11M | 1.27M | 945.2K |
Other Working Capital | -2.84M | 2.72M | -2.1M | -172K | 669.6K | 219.9K | 1.39M | -459K | -2.49M | n/a | 66.1K | 392.6K | 459.7K | -97.9K | 122.5K | 10K |
Other Non-Cash Items | 3.94M | 2.13M | 1.38M | 154K | 150.3K | -297.8K | 511.9K | 210K | 3.43M | 133.8K | 139.2K | 150.4K | -3.8M | 6.05M | n/a | -105.8K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -150.4K | 4.23M | -6.05M | n/a | n/a |
Change in Working Capital | -1.86M | 2.42M | -2.1M | -319K | -1.48M | -1.32M | -793.5K | 385K | -1.63M | 4.73M | 1.74M | -474K | 459.7K | 76.3K | -109.3K | 283.6K |
Operating Cash Flow | -3.65M | -1.93M | -8.18M | -5.7M | -5.41M | -5.23M | -6.46M | -4.13M | -4.1M | -6.1M | -5.97M | -7.58M | -9.17M | -4.81M | -3.71M | -2.64M |
Capital Expenditures | -28K | -219K | -98K | -21K | -109.1K | -97.5K | n/a | n/a | -57.2K | 132.4K | -2.47M | -2.48M | -1.1M | -206.9K | -545.9K | -44.7K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15K | n/a | n/a | n/a | 456K | 84K | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 15K | n/a | n/a | n/a | -456K | 84K | n/a | n/a |
Investing Cash Flow | -28K | -219K | -98K | -21K | -109.1K | -97.5K | n/a | n/a | -42.2K | 132.4K | -2.47M | -2.48M | -1.1M | -122.9K | -545.9K | -44.7K |
Debt Repayment | 2.42M | n/a | 8.78M | 6.19M | 4.34M | 7.03M | 6.23M | 5.84M | 4.56M | -114.9K | -170.8K | -168.8K | 454.6K | -91.6K | -136.2K | -134.6K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | -1.43M | -1.43M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 2.46M | 1.43M | n/a | n/a | -27.4K | n/a | -300K | -200K | n/a | n/a | n/a | n/a | 37.12M | 125.4K | n/a |
Financial Cash Flow | 2.42M | 1.03M | 8.78M | 6.19M | 4.34M | 7M | 7.11M | 5.54M | 4.36M | -114.9K | -170.8K | -168.8K | 454.6K | 37.03M | -10.8K | -134.6K |
Net Cash Flow | -1.26M | -1.12M | 503K | 472K | -1.18M | 1.68M | 649.9K | 1.41M | 212.5K | -6.08M | -8.61M | -10.23M | -9.81M | 32.09M | -4.26M | -2.82M |
Free Cash Flow | -3.68M | -2.15M | -8.28M | -5.72M | -5.52M | -5.33M | -6.46M | -4.13M | -4.16M | -5.96M | -8.44M | -10.06M | -10.26M | -5.02M | -4.25M | -2.68M |